2012 Fiscal Year Final Research Report

The role of glial cell in cancer pain, for a new strategy of cancer pain.

Research Project

Project/Area Number	22591757
Research Category	Grant-in-Aid for Scientific Research (C)
Allocation Type	Single-year Grants
Section	一般
Research Field	Anesthesiology/Resuscitation studies
Research Institution	National Cancer Center Japan (2011-2012) Research Institute, International Medical Center of Japan (2010)
Principal Investigator	SAITO Osamu 独立行政法人国立がん研究センター, 中央病院, 医長 (90344986)
Co-Investigator(Renkei-kenkyūsha)	AOE Tomohiko 千葉大学, 大学院・医学研究院, 准教授 (90311612) YAMAMOTO Tatsuo 熊本大学, 大学院・医学薬学研究院, 教授 (20200818)
Project Period (FY)	2010 – 2012
Keywords	疼痛管理学(がん性疼痛・緩和医療
Research Abstract	It has been reported that ibudilast can attenuate some kinds of pain, due to its potential as a glial cell modulator. Our study reported it could attenuate bone cancer pain in a mouse model. The result suggests that ibudilast could be useful for the treatment of bone cancer pain.